ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,821, issued on June 2, was assigned to COMPAGNIE GERVAIS DANONE (Gif-sur-Yvette, France).
"Use of Akkermansia for treating metabolic disorders" was invented by Patrice Cani (Brussels), Amandine Everard (Ottignies, Belgium), Clara Belzer (Wageningen, Netherlands) and Willem De Vos (Ede, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising Akkermansia muciniphila or fragments thereof for treating a ...